Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I also," hope they sell a lot of tests." And that
Steve Barnhill becomes a multi millionaire, because
of that.
bg
Thanks rocketeer, I hadn't seen that before. Now I'm hoping
for Dr. Barnhill to collect big bux for his new 10% bonus deal. I've added another 80,000 shares this past week, and it looks like I better be adding more, the way things are developing here.
bg
rocket, do you have a link for your post?
tia
With these results, it's one heck of a buy at 5 cents.
Press Release Source: Health Discovery Corporation
Health Discovery Corporation Announces Successful Clinical Trial Results for New Molecular Diagnostic Test for Prostate Cancer
Wednesday April 30, 4:16 pm ET
New Prostate Cancer Test Demonstrates Very High Accuracy Rate for Detecting Prostate Cancer
SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (“HDC”) (OTCBB: HDVY - News) today announced the successful clinical trial results for HDC’s new molecular diagnostic test for prostate cancer licensed exclusively to Clarient (Nasdaq:CLRT - News), in which HDC will receive a 30 percent royalty based on reimbursements received by Clarient from third parties.
ADVERTISEMENT
The initial clinical validation study recently completed at Clarient from prostate tissues obtained in collaboration with MD Anderson Cancer Center demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells (clinically significant cancer) in prostate cancer tissue. The new molecular diagnostic test achieved a Sensitivity of 100% meaning that the test correctly identified genomic evidence of prostate cancer cells in every tissue specimen known to be positive for prostate cancer. The test also demonstrated a very high success rate for correctly identifying those prostate specimens that did not have prostate cancer as being negative for prostate cancer and achieved a Specificity of 80% for identifying the non-cancer tissues, which included normal and benign prostatic hypertrophy (BPH) tissue, as not having genomic evidence of cancer.
In the United States alone there are over 1 million prostate cancer tissue biopsy procedures performed annually. Approximately 25% of these tissue biopsies are reported “positive” indicating the presence of prostate cancer. The other 75% of prostate cancer tissue biopsies are reported as “negative” for the presence of cancer. However, one-third of the men with prostate cancer tissue biopsies that are reported as “negative” for prostate cancer (roughly 25%) actually do have prostate cancer that was missed by the first biopsy (False Negative). These men actually have prostate cancer that was missed by the initial tissue biopsy for a variety of reasons. Health Discovery Corporation’s prostate cancer molecular diagnostic test is a genomics based test discovered using HDC’s patented SVM and SVM-RFE pattern recognition technology. This prostate cancer test is based on a unique combination of 4 genes that accurately identify the presence of Grade 3 or higher (clinically significant cancer) prostate cancer cells in prostate tissue.
HDC and Clarient will now move to phase two of the clinical trial process to increase the number of specimens tested in order to achieve the statistical significance necessary to validate these very successful initial results. Once the next phase of clinical testing is completed, The Companies will begin the commercialization process. Assuming the data continues to support these initial findings, it is possible that the product could be made available for clinical use by late Q3 of 2008 under the current CLIA regulations.
“We are thrilled with the results of this clinical trial and look forward to the commercial launch of this new prostate cancer test with Clarient,” stated Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “The success of this clinical trial also demonstrates that HDC, using our patented SVM and SVM-RFE technology, can develop new molecular diagnostic tests from conception of the idea through clinical discovery and validation of unique genomic signatures that can be commercialized as new molecular diagnostic tests. Our patent protected discovery method allows to us to develop molecular diagnostic tests that are free of outside intellectual property rights and thereby allows HDC to fully patent protect our discovery. We are currently duplicating this process to develop new molecular diagnostic tests in a variety of other cancers.”
Dr. Barnhill continued “We are looking forward to having HDC’s new prostate cancer test commercialized like similar molecular diagnostic tests based on unique gene expression profiles such as OncotypeDX from Genomic Health, Inc. (NasdaqGM:GHDX - News) and MammaPrint from Agendia.”
“The results of this clinical trial demonstrating genomic evidence of the presence of prostate cancer in prostate cancer tissue with 100% accuracy is a remarkable accomplishment,” stated Dr. Herbert Fritsche, Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, M.D. Anderson Cancer Center in Houston, Texas. “Health Discovery Corporation’s ability to develop state-of-the-art molecular diagnostic tests for cancer combined with Clarient’s ability to successfully commercialize these tests can provide a significant benefit to cancer patients and their physicians.”
Savannah-based Health Discovery Corporation (OTCBB: HDVY - News) is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a biology-oriented biomarker discovery company providing all aspects of First-Phase Biomarker Discovery(sm). The Company's SVM and FGM pattern recognition tools have significant application potential in other sizable commercial markets such as radiology, financial markets, Internet search and spam, homeland security, and other areas where analysis of large volumes of complex data is required.
This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the management team of HDC believes that the expectations reflected in such forward-looking statements are reasonable, they can give no assurance that such expectations will prove correct.
Contact:
Degreed, any comments on this drastic sell off,
would be appreciated. TIA
gg
It meant to say, "the companys"bored director",
that being CB.
Drillbit said that Charley said,"let the shareholders
eat cake".
'nuff said?
whocares witchever?
lmfao!
Mineral Wells is out of control!
rost, you and fish1031forbreakfast, keep me
lmfao!
and I too want to give you dudes the clap as well!
lmfao!
Same as, what if we never hear from SILLYUNCLECARL again.
Ho Hummmmmmmm!
I think you've got it right! Col. Sanders, wind machines,
lotsa ballyhoo, innuendos, vague PRs, and sell them shares.
just ask his sows!
freemarker, swing by chicago and pick up witchever, and
take her with you. Not only can she share expenses, but
she won't wimp out with CB, like gratsiazz did. She'll get
all the answers. One tough gal, and two can eat as cheap as one at mickeyDs.
gl
fleamarket, there are alot of locals you can bunk with, like steadyT, shiney, or better yet maybe Amanda B.
gl
fish1031forbreakfast, but you got that "so valuable"
looooooow outstanding shares, that you wanted.
FARMBOY, aenp isn't on the pinksheets YET. It is still
an OTCBB stock listed company. Doesn't Greyhound still
run from Ohio to Texass, if so get off your lazyass and you
go check out uncle charlie and co., or STFU!
CTB, I hope you and your family are safe in your new home,
and manage to escape the terrible fires down your way. SoCal
and San Diego Co.in particular is catching hell. Good luck,
bg
ctb, my two cents over a ,012 cent subject. About 2 years or so ago, the P&Der drillbit, just back from a "visit" with
uncle chollie, quoted CB as saying, in regards to the AMEP shareholders, "let them eat cake", or I guess,screw them. I
believe it was on RB, and was when drillbit was active doing
his thing, mis-leading other shareholders.
Check with him, he'll own up to it, depending which way he really wants to see the sp go.
bg
gloer, nice that you vouch for CB. Now who can you get
to do the same for you?
BTW, several people have asked you about your $$ check from
uncle joe, from the "profits" of your well investment, any
answer yet?
whichever way you decide to go, you should remind
etrade that you're a dedicated LONG holder of amep/aenp.
Then they will feel sorry for you, and probably waive
any fees, and wish you fare thee well.
the trading record shows that 7 out of 8 of
the trades made in the last 2 hours today were
below yesterdays close. Only a $53 buy in the
last 4 minutes, was up. This is called painting the tape.
GLTY
Time & Sales
Price Size Exch Time
0.53 100 OBB 15:55:53
0.36 200 OBB 15:37:24
0.31 200 OBB 15:37:24
0.335 1560 OBB 14:30:56
0.325 799 OBB 14:06:25
0.35 100 OBB 13:52:46
0.35 1363 OBB 13:02:27
0.36 1363 OBB 13:02:27
0.45 617 OBB 13:02:23
0.40 5000 OBB 13:02:23
0.45 142 OBB 12:33:14
0.40 142 OBB 12:33:14
0.50 1189 OBB 11:28:58
0.50 300 OBB 11:28:56
0.50 1999 OBB 11:28:56
0.50 1000 OBB 11:28:56
0.50 512 OBB 11:28:54
0.45 1200 OBB 11:18:25
0.45 100 OBB 10:38:20
0.45 100 OBB 10:38:16
0.45 100 OBB 10:38:12
0.40 100 OBB 10:28:17
0.35 500 OBB 10:28:16
0.55 150 OBB 10:12:32
0.35 500 OBB 10:10:34
0.35 2000 OBB 09:35:15
0.26 720 OBB 09:30:16
0.40 5000 OBB 09/19
0.40 340 OBB 09/19
0.44 100 OBB 09/19
bid .20 ask .50 eom
RJ, enquiring minds want to know,are those goose
pimples on her butt, or does the young lady have heat rash,
or?
RJ, is that a picture of govorchin?
Wow, no wonder fish1031 has been chasing
her. Nice cheeks!
new symbol is AENP. kinda has a ring to it, a death knell!
Yes to eturd, still there. They do charge for the symbol change, and they hit you for EACH account. I would
imagine it's the same for the other crooks.
ltg, I think there is a symbol change, and the
opportunity for Etrade etal, to charge their customers
a $20/25 charge per account for paperwork.
If indeed there is a change, it'll be effective at the opening, and will bwe accompanied by confusion.
When you call JC and demand news, don't forget to
tell him that fish got laid this past weekend,
(he thinks).
lmfao!
gratli, now if fish can do the update, even you should be able to navigate the process. Of course I almost forgot, fish says he got laid over the weekend too. Ah, another dream, and all wet
as usual.
lmfao!
Ah yes, more fodder for your girly friend
govonherchin. She must think she's the only one here
with a computer, and she's doing a favor to mankind
and of course newbys.
lmfao!
keithman, not only has the rm been approved, but now
the bm is happening to some of the lemming "yes" voters.
Kinda quiet here now.
Let's hear that pep talk, falconer!
lmfao!
It looks like the moderator of this board must have
jumped ship, oe he would surely add you to the list of bans.
You're nothing but a scavenger, preying on good people
who are losing their money here, in hopes that you might buy
even cheaper, and start your crap all over again.
Back to the farm, harry0.
Kid, I agree. Does anyone know if Scottrade is taking trades on line,as yet?
reality, E*Trade still thinks there is something wrong here.
Orders for this security cannot be accepted online at this time. For assistance with placing this order, please call Customer Service at 1-800-ETRADE-1 (1-800-387-2331).
I have to wonder if this presentation is being
put on by Amanda Bitters, the communication expert.
curley, you've got that right! eom
MrD, I can hear you laughing!